| (USD) | Dec 2022 | Q/Q |
|---|---|---|
| Revenue | 217.3MM | +3% |
| Operating Income | -141.8MM | +19% |
| Operating Expenses | 359MM | - |
| Net Income | -142.6MM | +17% |
| R&D | 87.9MM | +34% |
| G&A | 143.8MM | -3% |
| Interest Expense | 2.8MM | +18% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
AUSTIN, Texas, May 01, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its first quarter ended March 31, 2024, after the market close on May 9, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).
AUSTIN, Texas, May 01, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced the launch of a new cfDNA-based fetal RhD test. This comes at a critical time for the healthcare industry, helping physicians navigate patient care given nationwide shortages of Rho(D) immune globulin therapy (RhIg).
Natera Inc (NASDAQ:NTRA), a leader in personalized genetic testing and diagnostics, has seen a recent insider transaction according to the latest SEC Filing.
In this article, we will take a detailed look at the 10 Cathie Wood Stocks Insiders are Selling. For a quick overview of such stocks, read our article 5 Cathie Wood Stocks Insiders are Selling. There was a time Cathie Wood talked about her famous “five-year investment horizon” with confidence, giving investors hope that the high-growth, cash-burning companies she […]
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
Michael Brophy, the Chief Financial Officer of Natera Inc (NASDAQ:NTRA), has sold 1,523 shares of the company on April 23, 2024, according to a recent SEC filing.
Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), has sold 2,552 shares of the company on April 23, 2024, according to a recent SEC Filing.
AUSTIN, Texas, April 22, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that it has passed a significant milestone with the publication of more than 200 peer-reviewed papers highlighting Natera’s technology in the scientific literature.
Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), has sold 6,816 shares of the company on April 15, 2024, according to a recent SEC Filing.
Persistent inflation and an escalating war in the Middle East are putting pressure on the stock market while giving investors an impetus to find safe havens. The S&P 500 has lost more than 3.5% so far this month, as nervous investors held back from stocks. But not all stocks are losing traction in the face of these headwinds. Some stocks offer investors an array of supportive factors, strengths that can see them through a wide range of powerful difficulties. The Smart Score tool, from TipRanks,